4 completed, 1 recruiting, 1 terminated. 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Tioga Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS). Asimadoline - Vasomotor Symptoms | Phase 2 | Recruiting | Tioga Pharmaceuticals | 120 | 2025-08-13 | 2026-10-08 |
| Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis Asimadoline, Placebo - Pruritus, Atopic Dermatitis | Phase 2 | Completed | Tioga Pharmaceuticals | 249 | 2015-07-01 | 2017-12-13 |
| A Metabolite Identification, Mass Balance, and PK Study of [14C]-Asimadoline to Healthy Adult Male Volunteers asimadoline - Healthy | Phase 1 | Completed | Tioga Pharmaceuticals | 6 | 2011-06-01 | 2011-10-18 |
| Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Asimadoline, Placebo - Diarrhea Predominant Irritable Bowel Syndrome | Phase 3 | Completed | Tioga Pharmaceuticals | 611 | 2010-05-01 | 2013-12-18 |
| Asimadoline for the Treatment of Post-Operative Ileus Asimadoline, Placebo - Post-Operative Ileus | Phase 2 | Terminated | Tioga Pharmaceuticals | 35 | 2007-01-01 | 2012-01-06 |
| Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome Asimadoline, Placebo - Irritable Bowel Syndrome | Phase 2 | Completed | Tioga Pharmaceuticals | 596 | 2006-08-01 | 2011-10-18 |
Dermatitis, Atopic (1) · Hot Flashes (1) · Irritable Bowel Syndrome (1) · Pruritus (1)
asimadoline (6) · Clinical Coding (1)
United States (6)
Allen Mangel, MD, PhD (2) · Allen Mangel, M.D.Ph.D. (1) · Dawn McGuire, MD FAAN (1) · Dr. Philip Leese (1) · Sergey Sikora, VP of Clinical Affairs and COO, PhD (1)